Form 4 for NEO NEOGENOMICS INC
Accepted 2021-07-15 00:00:00 ET · period of report 2021-06-18 · accession 0001077183-21-000196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-15 | 2021-06-18 | NEO | Morris Clive | Pres of Inivata | A - Grant | $0.00 | +10.7K | 10.7K | New | $0 |
| D | 2021-07-15 | 2021-06-18 | NEO | Morris Clive | Pres of Inivata | A - Grant | $43.58 | +53.9K | 53.9K | New | +$2.35M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-18 | A | A | 10,708 | $0.00 | 10,708 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-06-18 | A | A | 53,857 | $43.58 | 53,857 | D | $43.58 · — to 2028-06-18 | 53,857 Common Stock | (F1) On June 18, 2021, Mr. Morris was granted 53,857 stock options. The options vest ratably over the first four anniversary dates of the grant date. |